These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2622330

  • 21. Outer membranes of a lipopolysaccharide-protein complex (LPS-17 kDa protein) as chemical tularemia vaccines.
    Khlebnikov VS, Golovliov IR, Kulevatsky DP, Tokhtamysheva NV, Averin SF, Zhemchugov VE, Pchelintsev SY, Afanasiev SS, Shcherbakov GY.
    FEMS Immunol Med Microbiol; 1996 Mar; 13(3):227-33. PubMed ID: 8861034
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
    Chen W, Shen H, Webb A, KuoLee R, Conlan JW.
    Vaccine; 2003 Sep 08; 21(25-26):3690-700. PubMed ID: 12922099
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparative analysis of antibodies to Francisella tularensis antigens during the acute phase of tularemia and eight years later.
    Bevanger L, Maeland JA, Kvan AI.
    Clin Diagn Lab Immunol; 1994 Mar 08; 1(2):238-40. PubMed ID: 7496953
    [Abstract] [Full Text] [Related]

  • 26. Francisella tularensis resistance to bactericidal action of normal human serum.
    Sorokin VM, Pavlovich NV, Prozorova LA.
    FEMS Immunol Med Microbiol; 1996 Mar 08; 13(3):249-52. PubMed ID: 8861038
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.
    Fulop M, Mastroeni P, Green M, Titball RW.
    Vaccine; 2001 Aug 14; 19(31):4465-72. PubMed ID: 11483272
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prior infection with Type A Francisella tularensis antagonizes the pulmonary transcriptional response to an aerosolized Toll-like receptor 4 agonist.
    Walters KA, Olsufka R, Kuestner RE, Wu X, Wang K, Skerrett SJ, Ozinsky A.
    BMC Genomics; 2015 Oct 28; 16():874. PubMed ID: 26510639
    [Abstract] [Full Text] [Related]

  • 31. Identification, cloning, expression, and purification of Francisella lpp3: an immunogenic lipoprotein.
    Parra MC, Shaffer SA, Hajjar AM, Gallis BM, Hager A, Goodlett DR, Guina T, Miller S, Collins CM.
    Microbiol Res; 2010 Sep 20; 165(7):531-45. PubMed ID: 20006480
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis.
    Tärnvik A, Löfgren S.
    Infect Immun; 1975 Nov 20; 12(5):951-7. PubMed ID: 1193733
    [Abstract] [Full Text] [Related]

  • 34. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ, Crane DD, Wehrly TD, Bosio CM.
    Clin Vaccine Immunol; 2015 Jan 20; 22(1):119-28. PubMed ID: 25410207
    [Abstract] [Full Text] [Related]

  • 35. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
    Drabick JJ, Narayanan RB, Williams JC, Leduc JW, Nacy CA.
    Am J Med Sci; 1994 Aug 20; 308(2):83-7. PubMed ID: 8042659
    [Abstract] [Full Text] [Related]

  • 36. Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis.
    Tärnvik A, Holm SE.
    Infect Immun; 1978 Jun 20; 20(3):698-704. PubMed ID: 307538
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Francisella tularensis LVS surface and membrane proteins as targets of effective post-exposure immunization for tularemia.
    Chandler JC, Sutherland MD, Harton MR, Molins CR, Anderson RV, Heaslip DG, Bosio CM, Belisle JT.
    J Proteome Res; 2015 Feb 06; 14(2):664-75. PubMed ID: 25494920
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.